FIB-4 Index and Neutrophil-to-Lymphocyte-Ratio as Death Predictor in Coronary Artery Disease Patients

Nonalcoholic fatty liver disease (NAFLD)-associated liver fibrosis is likely related to coronary artery disease (CAD) by the mediation of systemic inflammation. This study aimed at evaluating the predictive value of neutrophil-to-lymphocyte-ratio (NLR) and fibrosis-4 index (FIB-4), indices of inflam...

Full description

Bibliographic Details
Main Authors: Melania Gaggini, Fabrizio Minichilli, Francesca Gorini, Serena Del Turco, Patrizia Landi, Alessandro Pingitore, Cristina Vassalle
Format: Article
Language:English
Published: MDPI AG 2022-12-01
Series:Biomedicines
Subjects:
Online Access:https://www.mdpi.com/2227-9059/11/1/76
_version_ 1827628264475066368
author Melania Gaggini
Fabrizio Minichilli
Francesca Gorini
Serena Del Turco
Patrizia Landi
Alessandro Pingitore
Cristina Vassalle
author_facet Melania Gaggini
Fabrizio Minichilli
Francesca Gorini
Serena Del Turco
Patrizia Landi
Alessandro Pingitore
Cristina Vassalle
author_sort Melania Gaggini
collection DOAJ
description Nonalcoholic fatty liver disease (NAFLD)-associated liver fibrosis is likely related to coronary artery disease (CAD) by the mediation of systemic inflammation. This study aimed at evaluating the predictive value of neutrophil-to-lymphocyte-ratio (NLR) and fibrosis-4 index (FIB-4), indices of inflammation and fibrosis, respectively, on CAD mortality. Data from 1460 CAD patients (1151 males, age: 68 ± 10 years, mean ± SD) were retrospectively analyzed. Over a median follow-up of 26 months (interquartile range (IQR) 12–45), 94 deaths were recorded. Kaplan–Meier survival analysis revealed worse outcomes in patients with elevation of one or both biomarkers (FIB-4 > 3.25 or/and NLR > 2.04, log-rank <i>p</i>-value < 0.001). In multivariate Cox regression analysis, the elevation of one biomarker (NLR or FIB-4) still confers a significant independent risk for mortality (hazard ratio (HR) = 1.7, 95% confidence interval (95% CI): 1.1–2.7, <i>p</i> = 0.023), whereas an increase in both biomarkers confers a risk corresponding to HR = 3.5 (95% CI: 1.6–7.8, <i>p</i> = 0.002). Categorization of patients with elevated FIB-4/NLR could provide valuable information for risk stratification and reduction of residual risk in CAD patients.
first_indexed 2024-03-09T13:30:11Z
format Article
id doaj.art-7184a74cd60142fbb7384ac83612256d
institution Directory Open Access Journal
issn 2227-9059
language English
last_indexed 2024-03-09T13:30:11Z
publishDate 2022-12-01
publisher MDPI AG
record_format Article
series Biomedicines
spelling doaj.art-7184a74cd60142fbb7384ac83612256d2023-11-30T21:19:06ZengMDPI AGBiomedicines2227-90592022-12-011117610.3390/biomedicines11010076FIB-4 Index and Neutrophil-to-Lymphocyte-Ratio as Death Predictor in Coronary Artery Disease PatientsMelania Gaggini0Fabrizio Minichilli1Francesca Gorini2Serena Del Turco3Patrizia Landi4Alessandro Pingitore5Cristina Vassalle6Institute of Clinical Physiology, National Research Council, 56124 Pisa, ItalyInstitute of Clinical Physiology, National Research Council, 56124 Pisa, ItalyInstitute of Clinical Physiology, National Research Council, 56124 Pisa, ItalyInstitute of Clinical Physiology, National Research Council, 56124 Pisa, ItalyInstitute of Clinical Physiology, National Research Council, 56124 Pisa, ItalyInstitute of Clinical Physiology, National Research Council, 56124 Pisa, ItalyFondazione Gabriele Monasterio, CNR-Regione Toscana, 56124 Pisa, ItalyNonalcoholic fatty liver disease (NAFLD)-associated liver fibrosis is likely related to coronary artery disease (CAD) by the mediation of systemic inflammation. This study aimed at evaluating the predictive value of neutrophil-to-lymphocyte-ratio (NLR) and fibrosis-4 index (FIB-4), indices of inflammation and fibrosis, respectively, on CAD mortality. Data from 1460 CAD patients (1151 males, age: 68 ± 10 years, mean ± SD) were retrospectively analyzed. Over a median follow-up of 26 months (interquartile range (IQR) 12–45), 94 deaths were recorded. Kaplan–Meier survival analysis revealed worse outcomes in patients with elevation of one or both biomarkers (FIB-4 > 3.25 or/and NLR > 2.04, log-rank <i>p</i>-value < 0.001). In multivariate Cox regression analysis, the elevation of one biomarker (NLR or FIB-4) still confers a significant independent risk for mortality (hazard ratio (HR) = 1.7, 95% confidence interval (95% CI): 1.1–2.7, <i>p</i> = 0.023), whereas an increase in both biomarkers confers a risk corresponding to HR = 3.5 (95% CI: 1.6–7.8, <i>p</i> = 0.002). Categorization of patients with elevated FIB-4/NLR could provide valuable information for risk stratification and reduction of residual risk in CAD patients.https://www.mdpi.com/2227-9059/11/1/76fibrosis-4 indexFIB-4neutrophil-to-lymphocyte-ratioNLRhepatic fibrosissystemic inflammation
spellingShingle Melania Gaggini
Fabrizio Minichilli
Francesca Gorini
Serena Del Turco
Patrizia Landi
Alessandro Pingitore
Cristina Vassalle
FIB-4 Index and Neutrophil-to-Lymphocyte-Ratio as Death Predictor in Coronary Artery Disease Patients
Biomedicines
fibrosis-4 index
FIB-4
neutrophil-to-lymphocyte-ratio
NLR
hepatic fibrosis
systemic inflammation
title FIB-4 Index and Neutrophil-to-Lymphocyte-Ratio as Death Predictor in Coronary Artery Disease Patients
title_full FIB-4 Index and Neutrophil-to-Lymphocyte-Ratio as Death Predictor in Coronary Artery Disease Patients
title_fullStr FIB-4 Index and Neutrophil-to-Lymphocyte-Ratio as Death Predictor in Coronary Artery Disease Patients
title_full_unstemmed FIB-4 Index and Neutrophil-to-Lymphocyte-Ratio as Death Predictor in Coronary Artery Disease Patients
title_short FIB-4 Index and Neutrophil-to-Lymphocyte-Ratio as Death Predictor in Coronary Artery Disease Patients
title_sort fib 4 index and neutrophil to lymphocyte ratio as death predictor in coronary artery disease patients
topic fibrosis-4 index
FIB-4
neutrophil-to-lymphocyte-ratio
NLR
hepatic fibrosis
systemic inflammation
url https://www.mdpi.com/2227-9059/11/1/76
work_keys_str_mv AT melaniagaggini fib4indexandneutrophiltolymphocyteratioasdeathpredictorincoronaryarterydiseasepatients
AT fabriziominichilli fib4indexandneutrophiltolymphocyteratioasdeathpredictorincoronaryarterydiseasepatients
AT francescagorini fib4indexandneutrophiltolymphocyteratioasdeathpredictorincoronaryarterydiseasepatients
AT serenadelturco fib4indexandneutrophiltolymphocyteratioasdeathpredictorincoronaryarterydiseasepatients
AT patrizialandi fib4indexandneutrophiltolymphocyteratioasdeathpredictorincoronaryarterydiseasepatients
AT alessandropingitore fib4indexandneutrophiltolymphocyteratioasdeathpredictorincoronaryarterydiseasepatients
AT cristinavassalle fib4indexandneutrophiltolymphocyteratioasdeathpredictorincoronaryarterydiseasepatients